iShares US Pharmaceuticals ETF
IHE
IHE
110 hedge funds and large institutions have $98.2M invested in iShares US Pharmaceuticals ETF in 2021 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 23 increasing their positions, 26 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
12% less repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 26
Holders
110
Holding in Top 10
–
Calls
$6K
Puts
–
Top Buyers
| 1 | +$1.65M | |
| 2 | +$902K | |
| 3 | +$849K | |
| 4 |
AWM
AE Wealth Management
Topeka,
Kansas
|
+$643K |
| 5 |
Morgan Stanley
New York
|
+$340K |
Top Sellers
| 1 | -$2.28M | |
| 2 | -$2.13M | |
| 3 | -$951K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$219K |
| 5 |
AFG
Arkansas Financial Group
Little Rock,
Arkansas
|
-$202K |